Medicine for treating myasthenia gravis and preparation method of medicine

A technology for myasthenia gravis and drugs, which is applied in drug combinations, pharmaceutical formulations, medical preparations containing active ingredients, etc., can solve problems such as dependence and side effects, easy recurrence, and cure the symptoms but not the root cause, and achieves convenient administration and remarkable curative effect. , the effect of unique curative effect

Inactive Publication Date: 2015-04-01
李爱花
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, myasthenia gravis is a disease that is difficult to cure. Some drugs can only treat the symptoms but not the root cause, and often have dependence and side effects. After curing, it is easy to relapse, and the treatment effect is not good.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating myasthenia gravis and preparation method of medicine
  • Medicine for treating myasthenia gravis and preparation method of medicine
  • Medicine for treating myasthenia gravis and preparation method of medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] The raw material composition and the weight of active ingredient of medicine of the present invention are:

[0042]

[0043] A preparation method of a medicine for treating myasthenia gravis, comprising the following process steps:

[0044] (1) Wash white fungus, floating wheat, chrysanthemum and pleurotus, put them into a container, add 8 to 10 times the amount of distilled water, soak for 5 to 6 hours, boil for 3 to 4 hours, and extract; add 6 to 8 Double the amount of distilled water, boil for 2 to 3 hours, and extract; finally, add 4 to 6 times the amount of distilled water, heat and boil for 1 to 2 hours, and extract; combine the three extracts, filter, and obtain the filtrate, which is concentrated to a relative density of 1.10 at 60°C ~1.13 thick paste, set aside;

[0045] (2) Wash hexagonal vine, pearl umbrella, striae vine, tartary buckwheat head, ground walnut and bean leaf seven, soak in 5 times the amount of 80% ethanol solution for 1 to 2 hours, heat an...

Embodiment 2

[0050] The raw material composition and the weight of active ingredient of medicine of the present invention are:

[0051]

[0052] The process steps, usage and dosage of the medicine preparation method in this embodiment are the same as those in Example 1.

Embodiment 3

[0054] The raw material composition and the weight of active ingredient of medicine of the present invention are:

[0055]

[0056] The process steps, usage and dosage of the medicine preparation method in this embodiment are the same as those in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine for treating myasthenia gravis and a preparation method of the medicine and belongs to the field of traditional Chinese medicines. Effective components of the medicine comprise raw materials as follows: white fungus, roots of wingedstem treebine, insects, ardisia maculosa, Chinese starjasmine stems, Chinese yams, silk cotton, tartarian buckwheat root tubers, herbs of hairy fruit violet, hazelnuts, light wheat, honeycombs, chrysanthemum morofolium ramat, whole herbs of stylophorum lasiocarpum, pleurotus ostreatus and antlers. Medicinal materials of the medicine are compatible, the medicine conforms to traditional Chinese medicine and modern medicine theories, has effects of nourishing the liver and the kidney, strengthening the spleen, removing blood stagnation, calming the liver and improving eyesight, has the unique curative effect on the myasthenia gravis and is significant in curative effect, convenient to take, safe and free of toxic and side effects, the pain of myasthenia gravis patients is relieved, the myasthenia gravis does not recur after cured, and both symptoms and root causes can be treated.

Description

Technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a medicine for treating myasthenia gravis and a preparation method thereof. Background technique [0002] Myasthenia gravis is an autoimmune disease caused by dysfunction of the nerve-muscle junction. The main clinical manifestations are partial or general skeletal muscle weakness and fatigue. The symptoms are aggravated after activities and relieved after rest. The prevalence rate is 77-150 / 1 million, and the annual incidence rate is 4-11 / 1 million. The prevalence rate of women is higher than that of men, about 3:2, and the disease occurs in all age groups. The causes of myasthenia gravis are divided into two categories, one is congenital hereditary, which is extremely rare and has nothing to do with autoimmunity; the second is autoimmune disease, which is the most common. The cause of the disease is not yet clear, but it is generally believed to be related to infe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/899A61P21/04A61K35/64A61K35/32
CPCA61K36/8945A61K36/899A61K9/20A61K35/32A61K35/63A61K36/06A61K36/07A61K36/185A61K36/24A61K36/28A61K36/41A61K36/70A61K36/86A61K36/87A61K2236/331A61K2236/333A61K2236/39A61K2236/51A61K2300/00
Inventor 李爱花
Owner 李爱花
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap